Renal Impairment Is Frequent in Chronic Hepatitis C Patients Under Triple Therapy With Telaprevir or Boceprevir Reply

被引：0
|
作者：
Gordon, Stuart C. [1 ]
Yee, Leland J. [2 ]
Martins, Eduardo Bruno [2 ]
机构：
[1] Henry Ford Hosp, Detroit, MI 48202 USA
[2] Gilead Sci, Foster City, CA USA
来源：
HEPATOLOGY | 2014年 / 59卷 / 06期
关键词：
D O I：
10.1002/hep.26902
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：2427 / 2427
页数：1
相关论文
共 50 条
  • [1] Renal impairment is frequent in chronic hepatitis C patients under triple therapy with telaprevir or boceprevir
    Mauss, Stefan
    Eisenbach, Christoph
    Heyne, Renate
    Moog, Gero
    Lutz, Thomas
    Naumann, Uwe
    Geissler, Michael
    Pape, Stefan
    Mordeja, Matthias
    Herold, Christoph
    Simon, Karl-Georg
    Isernhagen, Konrad
    Alshuth, Ulrich
    Buggisch, Peter
    Hueppe, Dietrich
    HEPATOLOGY, 2013, 58 : 1112A - 1112A
  • [2] Renal Impairment Is Frequent in Chronic Hepatitis C Patients Under Triple Therapy With Telaprevir or Boceprevir
    Mauss, Stefan
    Hueppe, Dietrich
    Alshuth, Ulrich
    HEPATOLOGY, 2014, 59 (01) : 46 - 48
  • [3] Renal Impairment Is Frequent in Chronic Hepatitis C Patients Under Triple Therapy With Telaprevir or Boceprevir
    Loustaud-Ratti, Veronique
    Carrier, Paul
    Vong, Chanlina
    Essig, Marie
    HEPATOLOGY, 2014, 59 (06) : 2426 - 2426
  • [4] Substantial Renal Impairment Is Not Infrequent in HCV Patients Under Triple Therapy With Telaprevir or Boceprevir
    Mauss, Stefan
    Eisenbach, Christoph
    Heyne, Renate
    Moog, Gero
    Lutz, Thomas
    Naumann, Uwe
    Geissler, Michael
    Mordeja, Matthias
    Herold, Christoph
    Simon, Karl Georg
    Milicic-Ouakili, Kerstin
    Buggisch, Peter
    Hueppe, Dietrich
    GASTROENTEROLOGY, 2013, 144 (05) : S960 - S960
  • [5] SUBSTANTIAL RENAL IMPAIRMENT IS NOT INFREQUENT IN HCV PATIENTS UNDER TRIPLE THERAPY WITH TELAPREVIR OR BOCEPREVIR
    Mauss, S.
    Eisenbach, C.
    Moeller, B.
    Moog, G.
    Lutz, T.
    Naumann, U.
    Geissler, M.
    Kroeger, T.
    Mordeja, M.
    Herold, C.
    Simon, K. -G.
    Felten, G.
    Milicic-Ouakili, K.
    Buggisch, P.
    Hueppe, D.
    JOURNAL OF HEPATOLOGY, 2013, 58 : S358 - S358
  • [6] Telaprevir or boceprevir triple therapy in patients with chronic hepatitis C and varying severity of cirrhosis
    Saxena, V.
    Manos, M. M.
    Yee, H. S.
    Catalli, L.
    Wayne, E.
    Murphy, R. C.
    Shvachko, V. A.
    Pauly, M. P.
    Chua, J.
    Monto, A.
    Terrault, N. A.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2014, 39 (10) : 1213 - 1224
  • [7] Effectiveness of telaprevir/boceprevir-based triple therapy for chronic hepatitis c
    Garcia-Queiruga, Marta
    Purificacion, Cid
    Laura Maria, Martinez-Lopez
    Marta, Leston
    Luis, Margusino
    Isabel, Martin
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACY, 2015, 37 (01) : 280 - 281
  • [8] A Small Percentage of Patients With Hepatitis C Receive Triple Therapy With Boceprevir or Telaprevir
    Chen, Emerson Y.
    Sclair, Seth N.
    Czul, Frank
    Apica, Betty
    Dubin, Perry
    Martin, Paul
    Lee, William M.
    CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2013, 11 (08) : 1014 - +
  • [9] Treatment of chronic hepatitis C genotype 1 with triple therapy comprising telaprevir or boceprevir
    Moradpour, Darius
    Muellhaupt, Beat
    SWISS MEDICAL WEEKLY, 2012, 142
  • [10] Hyperlipidemia in chronic hepatitis C under triple therapy with boceprevir
    Mata-Marin, J.
    Huerta-Garcia, G.
    Manjarrez-Tellez, B.
    Andrade-Fuentes, K.
    Sandoval-Ramirez, J.
    Martiinez-Rodriguez, M.
    JOURNAL OF VIRAL HEPATITIS, 2014, 21 : 35 - 36
12345